Caring Brands Business Summary

Caring Brands, Inc. (CABR) is a wellness-focused consumer products company that generates revenue through the direct-to-consumer sale and international licensing of proprietary, clinically validated over-the-counter (OTC) and cosmetic treatments. The company operates as a single business segment concentrated on hair growth, skin health, and women’s sexual wellness, with a portfolio featuring its patented Hair Enzyme Booster for hair loss and Photocil for psoriasis and vitiligo. Recently, the firm expanded its commercial footprint by securing an exclusive global license for Emesyl, an OTC nausea relief product, targeting a multi-billion dollar market. Within the competitive landscape, Caring Brands competes with small-cap consumer goods and wellness firms such as United-Guardian (UG), Aterian (ATER), and Natural Alternatives International (NAII), positioning itself as an IP-heavy, research-driven player transitioning from early-stage development to global commercial scaling. The leadership team is anchored by CEO Dr. Glynn Wilson, a veteran biopharmaceutical executive who previously served as CEO of TapImmune and Marker Therapeutics, bringing extensive experience from SmithKline Beecham and Ciba-Geigy. Executive Chairman Brian John, the founder of Caro Partners and former CEO of Safety Shot (formerly Jupiter Wellness), provides strategic oversight and a background in navigating public markets and corporate spin-offs. The financial operations are led by CFO Tyler Moore, who joined in late 2025 with a pedigree in technical accounting from Ernst & Young and executive roles at Benefytt and Health IQ. The company’s board includes notable industry figures such as Dr. Hector Alila and recently appointed legal expert Christopher Galeta, reflecting a governance structure designed to support its recent November 2025 uplisting to the Nasdaq Capital Market.